Potential of phosphodiesterase 4B inhibition in the treatment of progressive pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is often regarded as the archetypal progressive fibrosing interstitial lung disease (ILD). The term “progressive pulmonary fibrosis” (PPF) generally describes progressive lung fibrosis in an individual with an ILD other than IPF. Both IPF and PPF are associated wi...
Saved in:
| Main Authors: | Rebecca Keith, Anoop M. Nambiar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-01-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666241309795 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress on phosphodiesterase 4 inhibitors in the treatment of palmoplantar pustulosis
by: YAO Xinyi, et al.
Published: (2024-11-01) -
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases
by: Elizabeth R Volkmann, et al.
Published: (2024-12-01) -
Inhibition of phosphodiesterase‐4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination
by: Yasir A. Syed, et al.
Published: (2013-10-01) -
Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition.
by: Liping Sun, et al.
Published: (2014-01-01) -
Stimulation of Neural Stem Cell Proliferation by Inhibition of Phosphodiesterase 5
by: Ana I. Santos, et al.
Published: (2014-01-01)